As of 2025-06-22, the Relative Valuation of Revance Therapeutics Inc (RVNC) is (31.67) USD. This relative valuation is based on P/E multiples. With the latest stock price at 3.65 USD, the upside of Revance Therapeutics Inc based on Relative Valuation is -967.7%.
The range of the Relative Valuation is (30.18) - (31.31) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 17.0x - 17.7x | 17.5x |
| Forward P/E multiples | 17.1x - 19.6x | 18.4x |
| Fair Price | (30.18) - (31.31) | (31.67) |
| Upside | -926.8% - -957.8% | -967.7% |
| Date | P/E |